Biomanufacturing company Again has acquired Genomatica, known as Geno, in a deal announced from Copenhagen and San Diego. The acquisition combines Again’s biomanufacturing scale-up expertise with Geno’s AI-driven discovery and design platform. Terms of the deal were not disclosed.
Geno was founded in 1998 and built its reputation on industrial bioprocess engineering. Over the years, the company commercialized biological processes for widely used chemicals and materials. It also built one of the deepest proprietary bioprocess datasets in the industry, backed by an extensive patent portfolio. Manufacturers and consumer products companies worldwide have relied on its technology.
Again describes the deal as creating an end-to-end AI and computation stack for biomanufacturing. Geno brings two decades of experience in de novo molecule discovery, pathway design and predictive machine learning. That expertise will merge with Again’s existing bioprocess design suite.
The companies frame scaling, rather than simulation, as the harder challenge in biomanufacturing. By combining Geno’s simulation capabilities with Again’s scale-up modeling and engineering expertise, the merged platform aims to both design and scale new processes. Again says this should shorten the timeline from pathway design to industrial execution, and expand deployment across a wider range of feedstock sources.
The deal also lands at a notable moment for the industry. Reshoring efforts are accelerating under policies like the U.S. BIOSECURE Act and the EU’s Biotech Act II, both of which are expected to drive billions of dollars into domestic bio-based supply chains.
Max Kufner, CEO of Again, said algorithms only matter if they can translate into real-world, commercial-scale execution. He credited Geno with pioneering AI and computational biotechnology for molecule discovery and design. Kufner said integrating that work with Again’s scale-up platform and feedstock technologies positions the combined company to build what he called the leading biomanufacturing platform.
Again currently operates in Copenhagen, Munich and Houston, developing technologies for the industrial, personal and home care, food and feed markets. All existing Genomatica partners will continue to be supported through the transition, according to the announcement.
The post Again acquires Geno to unite AI design with biomanufacturing appeared first on World Bio Market Insights.
- Source: https://worldbiomarketinsights.com/again-acquires-geno-to-unite-ai-design-with-biomanufacturing/
